Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction

This phase II clinical trial with safety follow-up is designed to evaluate the efficacy and safety of Cellgram-ED (autologous bone marrow-derived mesenchymal stem cells) administered via intracavernous injection in patients with erectile dysfunction after radical prostatectomy.

Participants needed: 32
Trial details
Age: 19-80Biological sex: MaleType: ObservationalSponsor: Pharmicell Co., Ltd.Updated: Feb 24, 2026Locations: 4
Eligibility criteria

Participants who previously participated in the parent clinical trial and receiv... [+1]

Status: Recruiting

Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study

This Long-term follow-up is designed to evaluate the safety of patient with Alcoholic Liver Cirrhosis who had administered Cellgram-LC in PMC-P-07 study.

Participants needed: 100
Trial details
Biological sex: AllType: InterventionalSponsor: Pharmicell Co., Ltd.Updated: Mar 21, 2024Locations: 11
Eligibility criteria

Those who participated in PMC-P-07 clinical trials and received Cellgram-LC [+1]

Status: Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis

This phase III clinical trial is designed to evaluate the efficacy and safety of autologous Mesenchymal Stem Cells (MSC) injected hepatic artery.

Participants needed: 200
Trial details
Phase: Phase 3Age: 20-71Biological sex: AllType: InterventionalSponsor: Pharmicell Co., Ltd.Updated: Mar 21, 2024Locations: 11
Eligibility criteria

At the time of screening, 19 or 70 years [+6]

Those with a history of solid cancer including Hepatocellular Carcinoma (HCC) (w... [+24]